Inventor · disambiguated record
Jeremy Burrows
Also filed as: BURROWS JEREMY · BURROWS JEREMY N · BURROWS JEREMY NICHOLAS
14 granted patents·20 pending applications·136 citations·filing 1999–2021
91Inventor score
Top patents by PatentIndex Score
34 records- 0191US8598354B2Compounds having antiparasitic or anti-infectious activityRISCOE MICHAEL K·Filed 2011·Granted Dec 3, 2013·16 cites·35 claims
- 0286US9206131B2Compounds having antiparasitic or anti-infectious activityUNIV OREGON HEALTH & SCIENCE·Filed 2013·Granted Dec 8, 2015·5 cites·31 claims
- 0381US8178529B2Imidazole substituted pyrimidinesARVIDSSON PER I·Filed 2010·Granted May 15, 2012·15 cites·6 claims
- 0478US6667342B1Benzenesulfonamide-derivatives and their use as medicamentsASTRAZENECA AB·Filed 1999·Granted Dec 23, 2003·56 cites·11 claims
- 0575US6878712B1Amides as inhibitors for pyruvate dehydrogenaseASTRAZENECA AB·Filed 2000·Granted Apr 12, 2005·8 cites·13 claims
- 0673US6960602B2Piperidine derivatives as modulators of chemokine receptorsASTRAZENECA AB·Filed 2002·Granted Nov 1, 2005·7 cites·10 claims
- 0772US6989393B2Ccr5 modulators benzimidazoles or benzotriazolesASTRAZENECA AB·Filed 2001·Granted Jan 24, 2006·6 cites·6 claims
- 0872US6552225B1Chemical compoundsASTRAZENECA AB·Filed 2000·Granted Apr 22, 2003·7 cites·13 claims
- 0965US6689909B1Substituted N-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activityASTRAZENECA AB·Filed 2000·Granted Feb 10, 2004·3 cites·13 claims
- 1057US12509439B2Anti-malarial agentsUNIV KENTUCKY RES FOUND·Filed 2021·Granted Dec 30, 2025·0 cites·20 claims
- 1157US6498275B1Use of compounds for the elevation of pyruvate dehydrogenase activityASTRAZENECA AB·Filed 1999·Granted Dec 24, 2002·12 cites·9 claims
- 1256US9238653B2Antimalarial agents that are inhibitors of dihydroorotate dehydrogenaseRATHOD PRADIPSINH K·Filed 2010·Granted Jan 19, 2016·1 cites·19 claims
- 1351US2008214560A1Use of Pyrimidine Derivatives in the Manufacture of a Medicament for Prevention and/or Treatment of Alzheimer's DiseaseASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 1450US2006063818A1Hydantoin derivatives and deren verwendung als tace inhibitorenBURROWS JEREMY N·Filed 2003·Application pending·0 cites
- 1550US2005256176A1Sulphonamide derivatives and their use as tace inhibitorsBURROWS JEREMY N·Filed 2003·Application pending·0 cites
- 1649US6960688B2Use of compounds for the elevation of pyruvate dehydrogenase activityASTRAZENECA AB·Filed 2002·Granted Nov 1, 2005·0 cites·11 claims
- 1747US2009233943A9New compounds 835ASTEX THERAPEUTICS LTD·Filed 2008·Application pending·0 cites
- 1844US2006019994A1I-sulphonlyl piperidine derivativesBURROWS JEREMY N·Filed 2003·Application pending·0 cites
- 1944US2006142336A1N-sulfonylpiperidines as metalloproteinase inhibitors (tace)BURROWS JEREMY N·Filed 2003·Application pending·0 cites
- 2044US2010234593A1Imidazo[4,5-B]Pyridine-7-Carboxamides 704ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 2143US9464057B2Anti-malarial agentsMEDICINES FOR MALARIA VENTURE MMV·Filed 2014·Granted Oct 11, 2016·0 cites·10 claims
- 2243US2009233930A9Novel 2-Amino-Imidazole-4-One Compounds and Their Use in the Manufacture of a Medicament to Be Used in the Treatment of Cognitive Impairment, Alzheimer's Disease, Neurodegeneration and DementiaASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 2343US2009023762A1Substituted 2-Aminopyrimidine-4-Ones, Their Pharmaceutical Compositions And Their Use In The Treatment And/Or Prevention Of Ab-Related PathologiesASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 2442US2006173041A1Sulphonylpiperidine derivatives containing an aryl or heteroaryl group for use as matrix metalloproteinase inhibitorsBURROWS JEREMY N·Filed 2003·Application pending·0 cites
- 2542US2008188502A1New Compounds IASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 2641US2011028489A1Pyrimidine Derivatives and Their Use for Treating Bone-Related DisordersANDERSSON LARS·Filed 2010·Application pending·0 cites
- 2741US2008188503A1New Compounds IIASTRAZENACA AB·Filed 2007·Application pending·0 cites
- 2841US2009105252A1Pyrimidine Derivatives and Their Use in Therapy as well as the Use of Pyrimidine Derivatives in the Manufacture of a Medicament for Prevention and/or Treatment of Alzheimer's DiseaseASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 2940US2004110952A1N-4-piperidinyl compounds as ccr5 modulatorsFiled 2002·Application pending·0 cites
- 3040US2004122049A1Novel piperidine derivatives as modulators of chemokine receptorFiled 2002·Application pending·0 cites
- 3140US2008255085A1Novel Imidazo [4,5-b] Pyridine Derivatives as Inhibitors of Glycogen Synthase Kinase 3 for Use in the Treatment of Dementia and Neurodegenerative DisordersASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 3240US2008255106A1Novel 2-Phenyl-Imidazo[4,5-B]Pyridine Derivatives as Inhibitors of Glycogen Synthase Kinase for the Treatment of Dementia and Neurodegenerative DisordersASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 3339US2006063783A1Sulphonylpiperidine derivatives containing an alkenyl or alkynyl moiety for use as matrix metalloproteinase inhibitorsASTRAZENECA AB·Filed 2003·Application pending·0 cites
- 3435US2004006081A1Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activityFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jeremy Burrows files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →